|Day Low/High||34.76 / 35.38|
|52 Wk Low/High||28.25 / 37.39|
Stocks hold slightly lower by mid-afternoon Wednesday as a greater build to inventories accelerates losses in crude oil.
The pharmaceutical giant says it has inked a deal for the development rights of some growing antibiotics businesses.
Mining stocks pull down London's benchmark index.
Stocks fall further into the red as a greater build to inventories accelerate losses in crude oil.
But we maintain the company is attractive to purchase for the secure, 3.4% dividend yield.
Pfizer is making another acquisition.
The acquisition of Medivation gives the pharma giant a top-selling oncology drug and an immediate profit boost.
Stock futures remain close to the flatline on Wednesday as investors await a critical speech from Federal Reserve Chair Janet Yellen at the end of the week.
Pescara Del Tronto was one of the hardest hit towns in Central Italy as an earthquake rattled the country overnight.
Pfizer buys antibiotics business from AstraZeneca; Tesla unveils Model S version that can go 300 miles on a single charge; U.S. stock futures rise slightly.
Central part of Italy hit by 6.2 magnitude earthquake.
Pfizer Inc. (NYSE:PFE) today announced that it has entered into an agreement with AstraZeneca to acquire the development and commercialization rights to its late-stage small molecule anti-infectives business, primarily...
Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc.
Earnings season is far from over, Cramer says, and the Fed chief gives a major speech Friday.
Wall Street will get more clues on the Fed's rate hike plans later this week, but uncertainty over what they might be led to jittery trading on Monday.
Stocks fluctuate Monday afternoon as a selloff in crude oil hits the energy sector and Federal Reserve speeches at the end of the week leave investors wary.
Shareholders of the oncology drug maker ought to be satisfied with the auction's conclusion.
Shares of biotech micro-cap Cyclacel Pharmaceuticals have doubled in price in the past 10 days. Call it the Lloyd Christmas effect.
Pfizer's $14 billion acquisition of Medivation is a strong purchase, according to Jim Cramer, who now wonders what Sanofi will do next.
Stocks fluctuate on Monday as doubts over a production freeze agreement from major oil-producing countries snapped crude oil's recent rally.
PFE is trading up on the announcement, and the deal should add to earnings in 2017.
Pfizer confirmed its $14 billion acquisition of cancer drugmaker Medivation on Monday.
Stock futures move lower on Monday as doubts over a production freeze agreement from major oil-producing countries leave crude oil in the lurch.
Pfizer agrees to acquire Medivation while Citi puts Foot Locker and Under Armour on the back-to-school shopping list.
A potential blockbuster drug deal is reportedly in the works.